Literature DB >> 26276376

Role of aetiology, diabetes, tobacco smoking and hypertension in hepatocellular carcinoma survival.

Elena Raffetti1, Nazario Portolani2, Sarah Molfino2, Gian Luca Baiocchi2, Rosa Maria Limina3, Giovanni Caccamo3, Rossella Lamera3, Francesco Donato3.   

Abstract

BACKGROUND: Aim of this study was to investigate the role of aetiology, diabetes, tobacco smoking and hypertension in the survival of patients with hepatocellular carcinoma.
METHODS: A prospective cohort of 552 patients (81.5% males, mean age 64.4 years) first diagnosed with hepatocellular carcinoma in 1995-2001 in Brescia, Italy, was retrospectively analyzed. Data on the presence of diabetes mellitus, hypertension, heavy alcohol intake and tobacco smoking were obtained from patients' clinical charts or interviews. Survival analysis was performed using univariate and multivariate methods (Cox proportional hazards model).
RESULTS: 33% had a history of heavy alcohol intake, 24.3% had viral hepatitis and 33.5% had both aetiologies. Diabetes, hypertension and tobacco smoking were found in 29.9%, 37.9% and 35.9%, respectively. During follow-up (median 19.9 months), the median survival was 19.9 (95% confidence interval [CI] 16.7-22.8) months. Using multivariate Cox regression models, alcohol-related liver disease and diabetes were found to be associated with mortality, with hazard ratios of 1.32 (95% CI 0.99-1.75) and 1.25 (95% CI 1.02-1.54), respectively. Hypertension and smoking habit did not influence survival.
CONCLUSIONS: Alcohol aetiology and the presence of diabetes were positively associated with patient mortality with hepatocellular carcinoma, whereas tobacco smoking and hypertension were not.
Copyright © 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Attributable risk; Clinical-pathologic features; Prognosis

Mesh:

Year:  2015        PMID: 26276376     DOI: 10.1016/j.dld.2015.07.010

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  7 in total

1.  Are Metabolic Signatures Mediating the Relationship between Lifestyle Factors and Hepatocellular Carcinoma Risk? Results from a Nested Case-Control Study in EPIC.

Authors:  Nada Assi; Duncan C Thomas; Michael Leitzmann; Magdalena Stepien; Véronique Chajès; Thierry Philip; Paolo Vineis; Christina Bamia; Marie-Christine Boutron-Ruault; Torkjel M Sandanger; Amaia Molinuevo; Hendriek C Boshuizen; Anneli Sundkvist; Tilman Kühn; Ruth C Travis; Kim Overvad; Elio Riboli; Marc J Gunter; Augustin Scalbert; Mazda Jenab; Pietro Ferrari; Vivian Viallon
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-21       Impact factor: 4.254

2.  Prognostic impact of diabetes mellitus on hepatocellular carcinoma: Special emphasis from the BCLC perspective.

Authors:  Yu-Wen Su; Po-Hong Liu; Chia-Yang Hsu; Yun-Hsuan Lee; Cheng-Yuan Hsia; Shu-Yein Ho; Ming-Chih Hou; Harn-Shen Chen; Teh-Ia Huo
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

3.  Impact of smoking habit on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma.

Authors:  Keita Kai; Hiroki Koga; Shinichi Aishima; Atsushi Kawaguchi; Koutaro Yamaji; Takao Ide; Junji Ueda; Hirokazu Noshiro
Journal:  World J Gastroenterol       Date:  2017-02-28       Impact factor: 5.742

4.  Effect of menopausal status on the survival and recurrence of sex-classified hepatocellular carcinoma after liver resection: a case-matched study with propensity score matching.

Authors:  Wenli Zhang; Fuchen Liu; Jian Huang; Xinggang Guo; Wei Dong; Shuxun Wei; Li Li; Xiuli Zhu; Weiping Zhou; Hui Liu
Journal:  Aging (Albany NY)       Date:  2020-11-24       Impact factor: 5.682

5.  The Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma Mortality.

Authors:  Chien-Hsieh Chiang; Chia-Wen Lu; Hsieh-Cheng Han; Shou-Hung Hung; Yi-Hsuan Lee; Kuen-Cheh Yang; Kuo-Chin Huang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.817

6.  A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD.

Authors:  Takumi Kawaguchi; Katsutoshi Tokushige; Hideyuki Hyogo; Hiroshi Aikata; Tomoaki Nakajima; Masafumi Ono; Miwa Kawanaka; Koji Sawada; Kento Imajo; Koichi Honda; Hirokazu Takahashi; Kohjiroh Mori; Saiyu Tanaka; Yuya Seko; Yuichi Nozaki; Yoshihiro Kamada; Hideki Fujii; Atsushi Kawaguchi; Tetsuo Takehara; Mikio Yanase; Yoshio Sumida; Yuichiro Eguchi; Masataka Seike; Masato Yoneda; Yasuaki Suzuki; Toshiji Saibara; Yoshiyasu Karino; Kazuaki Chayama; Etsuko Hashimoto; Jacob George; Takuji Torimura
Journal:  Sci Rep       Date:  2018-07-11       Impact factor: 4.379

7.  Impact of HCV Infection on Diabetes Patients for the Risk of End-Stage Renal Failure.

Authors:  Jyh-Chang Hwang; Ming-Yan Jiang; Yi-Hua Lu; Shih-Feng Weng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.